Production of another potential vaccine against COVID-19 will begin within weeks, its developers Sanofi and GlaxoSmithKline said Thursday as they launched a large trial enrolling 35,000 adult volunteers in the United States, Asia, Africa and Latin America.
from Section Page News - Modern Healthcare https://ift.tt/2RPsFgb
No comments:
Post a Comment